Scott Shofer
Pulmonary Disease · Durham, NCNPI 1538156070
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,000 of the $8,364 with a category attached, or 71.7%. Intuitive Surgical accounts for 82.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $7,028 and has fallen 96.9% since, to $218 in 2024.
Across 17 payments — averaging $492.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Pulmonx Corporation$1K
- Galvanize Therapeutics, Inc$186
- Cook Medical LLC$118
- Bard Peripheral Vascular, Inc.$109
- Cook Incorporated$32
Across 3 payments — averaging $27,458 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Erbe Elektromedizin GmbH$82K
What the payments were for
- Grants$320%
- Travel & lodging$1,67620%
- Food & beverage$6568%
- Education$6,00072%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $6,919 |
| Pulmonx Corporation | 5 | $1,000 |
| Galvanize Therapeutics, Inc | 1 | $186 |
| Cook Medical LLC | 1 | $118 |
| Bard Peripheral Vascular, Inc. | 1 | $109 |
| Cook Incorporated | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,883
- ION$3,000
- Pulmonx Endobronchial Valve EBV$891
- ALIYA SYSTEM$186
- Cook Medical Centesis & Drainage$118
- PowerPort M.R.I. Implantable Port$109
How this compares
$8,364 in reported general payments places this provider in the 75th percentile of 393 pulmonary disease providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 11 | $1,203 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $145 |
| Furosemide | 12 | $7 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Durham
- Eric MeltzerDurham$262K
- Scott PalmerDurham$132K
- Lake MorrisonDurham$112K
- Laurie SnyderDurham$101K
- Craig RackleyDurham$33K
- Robert TigheDurham$22K
- Isaretta RileyDurham$16K
- Michael PritchettPinehurst$1.3M
- Michael WertGreensboro$412K
- Eugene BleeckerWinston Salem$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.